login
login

Europe Daily Bulletin No. 7881

15 January 2001
Contents Publication in full By article 40 / 47
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The German bio-pharmaceuticals company MEDIGENE AG bought, for EUR 55 million, the 91% of the capital in the American bio-technology company, which it did not already hold. It had already acquired on the stock market 9% of the capital last year. Thanks to this operation MEDIGENE could increase its annual turnover to USD 1.5 billion against the present 500 million.

Contents

THE DAY IN POLITICS
GENERAL NEWS
TEXTS OF THE WEEK
ECONOMIC INTERPENETRATION
WEEKLY SUPPLEMENT